FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3005164673> ?p ?o ?g. }

• W3005164673 endingPage "1679" @default.
• W3005164673 startingPage "1666" @default.
• W3005164673 abstract "Initially discovered in human melanoma, CD146/MCAM is expressed on many tumors and is correlated with cancer progression and metastasis. However, targeting CD146 remains challenging since it is also expressed on other cell types, as vessel cells, where it displays important physiological functions. We previously demonstrated that CD146 is shed as a soluble form (sCD146) that vectorizes the effects of membrane CD146 on tumor angiogenesis, growth and survival. We thus generated a novel monoclonal antibody, the M2J‐1 mAb, which specifically targets sCD146, but not membrane CD146, and counteracts these effects. In our study, we analyzed the effects of sCD146 on the dissemination and the associated procoagulant phenotype in two highly invasive human CD146‐positive cancer cell lines (ovarian and melanoma). Results show that sCD146 induced epithelial to mesenchymal transition, favored the generation of cancer stem cells and increased the membrane expression of tissue factor. Treatment of cancer cells with sCD146 in two experimental models (subcutaneous xenografting and intracardiac injection of cancer cells in nude mice) led to increased tumor dissemination and procoagulant activity. The M2J‐1 mAb drastically reduced metastasis but also procoagulant activity, in particular by decreasing the number of circulating tumor microparticles, and blocked the relevant signaling pathways as demonstrated by RNA expression profiling experiments. Thus, our findings demonstrate that sCD146 mediates important pro‐metastatic and procoagulant effects in two CD146‐positive tumors. Targeting sCD146 with the newly generated M2J‐1 mAb could constitute an innovative strategy for preventing dissemination and thromboembolism in many CD146‐positive tumors." @default.
• W3005164673 created "2020-02-14" @default.
• W3005164673 creator A5002084245 @default.
• W3005164673 creator A5007824824 @default.
• W3005164673 creator A5014697014 @default.
• W3005164673 creator A5016979636 @default.
• W3005164673 creator A5034576499 @default.
• W3005164673 creator A5035222065 @default.
• W3005164673 creator A5042128602 @default.
• W3005164673 creator A5046792925 @default.
• W3005164673 creator A5048001360 @default.
• W3005164673 creator A5057609392 @default.
• W3005164673 creator A5085151012 @default.
• W3005164673 creator A5085339071 @default.
• W3005164673 creator A5090294191 @default.
• W3005164673 date "2020-02-22" @default.
• W3005164673 modified "2023-10-12" @default.
• W3005164673 title "Therapeutic targeting of soluble CD146/MCAM with the M2J‐1 monoclonal antibody prevents metastasis development and procoagulant activity in CD146‐positive invasive tumors" @default.
• W3005164673 cites W1828940258 @default.
• W3005164673 cites W1964081206 @default.
• W3005164673 cites W1964539791 @default.
• W3005164673 cites W1971169657 @default.
• W3005164673 cites W1972669392 @default.
• W3005164673 cites W1980119671 @default.
• W3005164673 cites W1984793417 @default.
• W3005164673 cites W1986935616 @default.
• W3005164673 cites W1992514491 @default.
• W3005164673 cites W1993459732 @default.
• W3005164673 cites W1993903733 @default.
• W3005164673 cites W1994997972 @default.
• W3005164673 cites W2000241906 @default.
• W3005164673 cites W2012634392 @default.
• W3005164673 cites W2014691022 @default.
• W3005164673 cites W2035031390 @default.
• W3005164673 cites W2035984476 @default.
• W3005164673 cites W2038047778 @default.
• W3005164673 cites W2038336061 @default.
• W3005164673 cites W2042633087 @default.
• W3005164673 cites W2054498037 @default.
• W3005164673 cites W2056025993 @default.
• W3005164673 cites W2066763853 @default.
• W3005164673 cites W2069171502 @default.
• W3005164673 cites W2070192318 @default.
• W3005164673 cites W2079656395 @default.
• W3005164673 cites W2089129295 @default.
• W3005164673 cites W2101322033 @default.
• W3005164673 cites W2114919734 @default.
• W3005164673 cites W2144403534 @default.
• W3005164673 cites W2158087543 @default.
• W3005164673 cites W2159438576 @default.
• W3005164673 cites W2265677187 @default.
• W3005164673 cites W2333971940 @default.
• W3005164673 cites W2339199066 @default.
• W3005164673 cites W2397217808 @default.
• W3005164673 cites W2755881093 @default.
• W3005164673 cites W2952035822 @default.
• W3005164673 cites W4244068819 @default.
• W3005164673 doi "https://doi.org/10.1002/ijc.32909" @default.
• W3005164673 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32022257" @default.
• W3005164673 hasPublicationYear "2020" @default.
• W3005164673 type Work @default.
• W3005164673 sameAs 3005164673 @default.
• W3005164673 citedByCount "12" @default.
• W3005164673 countsByYear W30051646732020 @default.
• W3005164673 countsByYear W30051646732021 @default.
• W3005164673 countsByYear W30051646732022 @default.
• W3005164673 countsByYear W30051646732023 @default.
• W3005164673 crossrefType "journal-article" @default.
• W3005164673 hasAuthorship W3005164673A5002084245 @default.
• W3005164673 hasAuthorship W3005164673A5007824824 @default.
• W3005164673 hasAuthorship W3005164673A5014697014 @default.
• W3005164673 hasAuthorship W3005164673A5016979636 @default.
• W3005164673 hasAuthorship W3005164673A5034576499 @default.
• W3005164673 hasAuthorship W3005164673A5035222065 @default.
• W3005164673 hasAuthorship W3005164673A5042128602 @default.
• W3005164673 hasAuthorship W3005164673A5046792925 @default.
• W3005164673 hasAuthorship W3005164673A5048001360 @default.
• W3005164673 hasAuthorship W3005164673A5057609392 @default.
• W3005164673 hasAuthorship W3005164673A5085151012 @default.
• W3005164673 hasAuthorship W3005164673A5085339071 @default.
• W3005164673 hasAuthorship W3005164673A5090294191 @default.
• W3005164673 hasBestOaLocation W30051646731 @default.
• W3005164673 hasConcept C10205521 @default.
• W3005164673 hasConcept C121608353 @default.
• W3005164673 hasConcept C126322002 @default.
• W3005164673 hasConcept C142724271 @default.
• W3005164673 hasConcept C159654299 @default.
• W3005164673 hasConcept C198826908 @default.
• W3005164673 hasConcept C203014093 @default.
• W3005164673 hasConcept C2777658100 @default.
• W3005164673 hasConcept C2779013556 @default.
• W3005164673 hasConcept C2779093498 @default.
• W3005164673 hasConcept C2780394083 @default.
• W3005164673 hasConcept C28328180 @default.
• W3005164673 hasConcept C502942594 @default.
• W3005164673 hasConcept C542903549 @default.
• W3005164673 hasConcept C71924100 @default.
• W3005164673 hasConcept C86803240 @default.

• next